Historical cvs News Stories

CVS Faces Tennessee Law, Antitrust and Option Pain.

Recent state legislation, a House antitrust probe and a surge in bearish options have combined to raise regulatory and sentiment risks for CVS Health. Investors should weigh potential store closures, competitive moves by rivals, and heightened volatility when assessing CVS in the S&P 500.

CVS Stock Hits Rough Patch After MA Rate Cut

CVS delivered record 2025 revenue but falling EPS and a near-flat Medicare Advantage rate proposal from CMS pressured sentiment. PBM reforms and biosimilar savings offer offsetting levers for margin recovery.

CVS Q4 Beat Lifts Shares; Medicare Rates Bite 2026

CVS Health posted stronger-than-expected Q4 results that pushed the stock higher, but proposed near-flat Medicare Advantage rate changes and insurer margin pressures keep downside risk for Aetna. Investors are weighing resilient retail/PBM performance against reimbursement and regulatory headwinds.

CVS Plunges After CMS MA Rate Shock, PBM Rules Now

A near-flat CMS Medicare Advantage rate proposal and fresh PBM transparency rules rattled CVS this week, triggering a sharp stock drop and renewed scrutiny of Aetna and Caremark revenue drivers. Operational cuts and broader sector moves provide context for investors reassessing near-term outlook.